Brief: Inventiva Says FDA's Fast Track Designation To Lanifibranor In NASH Encompasses Treatment With Compensated Cirrhosis

Inventiva SA

21/09/2021 21:05

Sept 21 (Reuters) - Inventiva SA  IVAA.PA :
    * INVENTIVA ANNOUNCES FDA DECISION THAT FAST TRACK
DESIGNATION
GRANTED TO LANIFIBRANOR IN NASH ENCOMPASSES THE TREATMENT OF
NASH WITH COMPENSATED CIRRHOSIS
    * INVENTIVA ANNOUNCES FDA DECISION THAT FAST TRACK
DESIGNATION
GRANTED TO LANIFIBRANOR IN NASH ENCOMPASSES THE TREATMENT OF
NASH WITH COMPENSATED CIRRHOSIS

Source text for Eikon:  ID:nGNX9SY1ng 
Further company coverage:  IVAA.PA 

 ((Reuters.Briefs@thomsonreuters.com;))